Inovio Pharmaceuticals Inc (NAS:INO)
$ 12.15 -0.64 (-5%) Market Cap: 314.81 Mil Enterprise Value: 239.21 Mil PE Ratio: 0 PB Ratio: 2.36 GF Score: 49/100

Q2 2022 Inovio Pharmaceuticals Inc Earnings Call Transcript

Aug 09, 2022 / 08:30PM GMT
Release Date Price: $25.2 (-11.02%)
Operator

Good afternoon, and welcome to the INOVIO Pharmaceuticals conference call.

(Operator Instructions) Please note, this event is being recorded.

I would now like to turn the conference over to Thomas Hong, Manager of Investor Relations. Please go ahead.

Thomas Hong

Good afternoon, and thank you for joining the INOVIO Second Quarter 2022 Financial Results Conference Call. Joining me today on today's call are Dr. Jacqui Shea, President and CEO; Mr. Peter Kies, Chief Financial Officer; Dr. Michael Sumner, Chief Medical Officer; Dr. Laurent Humeau, Chief Scientific Officer; Dr. David Liebowitz, Senior Vice President of Clinical Development for Infectious Diseases; and Dr. Jeffrey Skolnik, Senior Vice President of Clinical Development for Immuno-Oncology and HPV Therapeutics.

Today's call will review our corporate and financial information for the quarter ended June 30, 2022, as well as provide an update on our efforts to develop our DNA medicines platform. Following prepared remarks, we will conduct a question-and-answer segment.

During

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot